CONMED
CNMD
#2847
Rank
$3.91 B
Marketcap
$128.09
Share price
0.90%
Change (1 day)
15.58%
Change (1 year)
Categories

P/E ratio for CONMED (CNMD)

P/E ratio as of June 2023 (TTM): -39.9

According to CONMED's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -39.9034. At the end of 2021 the company had a P/E ratio of 66.2.

P/E ratio history for CONMED from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202166.2-80.48%
2020339209.56%
2019110149.33%
201844.071.68%
201725.6-69.85%
201684.9112.11%
201540.05.1%
201438.116.55%
201332.767.26%
201219.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
32.7-182.06%๐Ÿ‡บ๐Ÿ‡ธ USA
27.2-168.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
85.9-315.35%๐Ÿ‡บ๐Ÿ‡ธ USA
40.1-200.52%๐Ÿ‡บ๐Ÿ‡ธ USA
31.1-177.84%๐Ÿ‡บ๐Ÿ‡ธ USA
20.0-150.04%๐Ÿ‡บ๐Ÿ‡ธ USA
26.8-167.19%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.